Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We report a novel C-terminal MECP2 frameshift deletion (1135_1142delCCCGTG CC) in a 19-year-old woman with mental retardation and epilepsy.
|
15558314 |
2005 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
MECP2 mutations most frequently associated with epilepsy were T158M (74%) and R106W (78%), and less frequently R255X and R306C (both 49%).
|
20231667 |
2010 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Duplications encompassing the MECP2 gene on the Xq28 region have been described in male patients with moderate to severe mental retardation, absent speech, neonatal hypotonia, progressive spasticity and/or ataxia, recurrent severe respiratory infections, gastrointestinal problems, mild facial dysmorphisms (midface hypoplasia, depressed nasal bridge, large ears) and epilepsy.
|
22578097 |
2012 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Various mutations in the MECP2 gene have a different influence on epilepsy, unrelated to the severity of the general Rett phenotype.
|
25789914 |
2015 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We performed mutation screening of CDKL5 in 60 female patients who had been identified as negative for the methyl CpG-binding protein 2 gene (MECP2) mutations, but who had current or past epilepsy, regardless of the age of onset, type, and severity.
|
22867051 |
2012 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
To investigate the association between genotype (methyl-CpG-binding protein 2 (MECP2 gene mutation)) and epileptic seizure phenotype in Rett syndrome.
|
21764336 |
2011 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
BDNF polymorphism was the only genetic correlate with seizure onset, whereas MECP2 mutation type and location did not influence epilepsy.
|
20491871 |
2010 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Associations with MECP2 mutations or epilepsy were not demonstrated, contrary to previous findings.
|
21178819 |
2011 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
An ASD "comorbidity" can have several fundamentally-distinct causal origins: it can arise due to shared genetic risk between ASD and non-ASD phenotypes (e.g., ASD and microcephaly in the context of the MECP2 mutation), as a "secondary symptom" of ASD when engendered by the same causal influence (e.g., epilepsy in channelopathies associated with ASD), due to chance co-occurrence of ASD with a causally-independent liability (e.g., ASD and diabetes), or as the late manifestation of an independent causal influence on ASD (eg, attention-deficit/hyperactivity disorder).
|
31344460 |
2020 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Eight boys with a MECP2 gene duplication and epilepsy were retrospectively studied.
|
24703762 |
2014 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mean age at epilepsy onset was 25.8+/-14.1 months.All patients showed MeCP2 mutation.
|
19914805 |
2010 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
As a consequence of these findings SCN1A should be considered in the molecular routine screening in MECP2-negative individuals with RTT and early onset epilepsy.
|
30305042 |
2018 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We observed a partial MECP2 duplication in an adult male with epilepsy and mild neurocognitive impairment who was able to function independently; this phenotype has not previously been reported among males harboring gains in MECP2 copy number.
|
22883432 |
2012 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
All patients underwent video/EEG monitoring and molecular analysis of the MECP2 gene or, in negative cases, of the CDKL5 and FOXG1 genes.The frequency of epilepsy was 79%.
|
20728410 |
2010 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the cyclin-dependent kinase-like 5 (CDKL5) (NM_003159.2) gene have been associated with early-onset epileptic encephalopathies or Hanefeld variants of RTT(Rett syndrome).
|
24564546 |
2014 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Duplications involving the methyl-CpG-binding protein 2 gene (MECP2) locus at Xq28 have been frequently identified in male patients who exhibit a phenotype unique from that of Rett syndrome, which is mainly characterized by severe mental retardation, recurrent infections, and epilepsy.
|
22877836 |
2013 |
Epilepsy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, they did not exhibit other clinical features commonly observed in American-European patients with MECP2 duplication, including recurrent respiratory infections and epilepsy.
|
22909152 |
2012 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
LHGDN |
A novel familial MECP2 mutation in a young boy: clinical and molecular findings.
|
16966553 |
2006 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
CTD_human |
De novo variants in neurodevelopmental disorders with epilepsy.
|
29942082 |
2018 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
BEFREE |
In 2009, four families with a distal duplication of Xq28 not including MECP2 and mediated by low-copy repeats (LCRs) designated "K" and "L" were reported with intellectual disability and epilepsy.
|
29341460 |
2018 |
Epilepsy
|
0.400 |
Biomarker
|
disease |
BEFREE |
EEG features and epilepsy in MECP2-mutated patients with the Zappella variant of Rett syndrome.
|
20153689 |
2010 |
Epilepsy
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
MeCP2 expression was detected in 35 temporal neocortex tissue samples from patients with intractable TLE and 14 histologically normal temporal lobe tissue samples from trauma patients without epilepsy by reverse transcription-polymerase chain reaction (RT-PCR), immunohistochemistry and double-label immunofluorescence.
|
22707285 |
2012 |